12 Feb 2025 //
GLOBENEWSWIRE
22 Jan 2025 //
PRESS RELEASE
08 Jan 2025 //
FDA
07 Jan 2025 //
PR NEWSWIRE
26 Nov 2024 //
GLOBENEWSWIRE
19 Nov 2024 //
GLOBENEWSWIRE
30 Sep 2024 //
CONTRACT PHARMA
18 Sep 2024 //
GLOBENEWSWIRE
04 Sep 2024 //
GLOBENEWSWIRE
29 Aug 2024 //
GLOBENEWSWIRE
29 Aug 2024 //
GLOBENEWSWIRE
24 Jun 2024 //
PR NEWSWIRE
10 Jun 2024 //
PR NEWSWIRE
25 Mar 2024 //
PR NEWSWIRE
30 Aug 2023 //
PHARMACEUTICAL-TECHNOLOGY
27 Jun 2023 //
GLOBENEWSWIRE
24 May 2023 //
FDA
04 May 2023 //
BUSINESSWIRE
13 Jan 2023 //
FDA
21 Dec 2022 //
BUSINESSWIRE
15 Dec 2022 //
GLOBENEWSWIRE
14 Nov 2022 //
GLOBENEWSWIRE
10 Oct 2022 //
ECONOMIC TIMES
30 Aug 2022 //
NEUROSCIENCENEWS
27 Jul 2022 //
PRNEWSWIRE
13 Jul 2022 //
GLOBENEWSWIRE
29 Jun 2022 //
GLOBENEWSWIRE
08 Jun 2022 //
GLOBENEWSWIRE
08 Jun 2022 //
FDA
27 May 2022 //
FIERCEPHARMA
06 Apr 2022 //
FIERCEPHARMA
01 Mar 2022 //
BUSINESSWIRE
31 Jan 2022 //
PRNEWSWIRE
12 Jan 2022 //
GLOBENEWSWIRE
12 Jan 2022 //
GLOBENEWSWIRE
11 Jan 2022 //
PRNEWSWIRE
11 Jan 2022 //
BUSINESSWIRE
04 Jan 2022 //
BUSINESSWIRE
03 Jan 2022 //
TRIALSITENEWS
20 Dec 2021 //
GLOBENEWSWIRE
24 Nov 2021 //
GLOBENEWSWIRE
24 Nov 2021 //
PRNEWSWIRE
18 Nov 2021 //
PRNEWSWIRE
29 Oct 2021 //
PRNEWSWIRE
27 Oct 2021 //
PRNEWSWIRE
26 Oct 2021 //
BUSINESSWIRE
19 Oct 2021 //
ENDPTS
19 Oct 2021 //
GLOBENEWSWIRE
14 Oct 2021 //
GLOBENEWSWIRE
30 Sep 2021 //
PRNEWSWIRE
14 Sep 2021 //
GLOBENEWSWIRE
23 Jun 2021 //
PRNEWSWIRE
10 Jun 2021 //
GLOBENEWSWIRE
27 Apr 2021 //
GLOBENEWSWIRE
05 Mar 2021 //
PRNEWSWIRE
24 Feb 2021 //
BIOSPACE
15 Jan 2021 //
PRNEWSWIRE
05 Jan 2021 //
NEWSWISE
23 Jun 2020 //
GLOBENEWSWIRE